Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir and Asunaprevir vs Telaprevir in Japanese Genotype 1b HCV
NCT01718145Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daclatasvir, asunaprevir in hepatitis C virus infection, sponsored by Bristol Myers Squibb. Started Nov 2012; status: completed.
02
Drugs
daclatasvirasunaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01718145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718145.